Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor

Shanada Monestime, Dovena Lazaridis

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor'. Together they form a unique fingerprint.

Medicine & Life Sciences